People: Quest Diagnostics Inc (DGX.N)
DGX.N on New York Stock Exchange
107.61USD
21 Sep 2018
107.61USD
21 Sep 2018
Change (% chg)
$-0.32 (-0.30%)
$-0.32 (-0.30%)
Prev Close
$107.93
$107.93
Open
$108.08
$108.08
Day's High
$108.65
$108.65
Day's Low
$107.51
$107.51
Volume
640,579
640,579
Avg. Vol
253,873
253,873
52-wk High
$116.43
$116.43
52-wk Low
$90.21
$90.21
Ring, Timothy
Mr. Timothy M. Ring is Independent Director of the Company. Mr. Ring retired in 2017 as Chairman and Chief Executive Officer of C. R. Bard, Inc., positions in which he had served since 2003. He is a director of Becton, Dickinson and Company, and was director of C. R. Bard, Inc. from 2003 to 2017 and CIT Group Inc. from 2005 to 2009. Mr. Ring is a Trustee of the New Jersey Health Foundation.
Basic Compensation
| Total Annual Compensation, USD | 123,500 |
| Restricted Stock Awards, USD | 167,965 |
| Long-Term Incentive Plans, USD | -- |
| All Other, USD | -- |
| Fiscal Year Total, USD | 291,465 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Exercisable | -- | -- |
| Unexercisable | -- | -- |
| Exercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Stephen Rusckowski |
10,348,000 |
Mark Guinan |
3,460,400 |
James Davis |
3,270,240 |
Michael Prevoznik |
2,090,390 |
Jon Cohen |
2,491,990 |
Everett Cunningham |
-- |
As Of
30 Dec 2017